The DOI matches its Crossref record.
A Replication-Defective Human Adenovirus Recombinant Serves as a Highly Efficacious Vaccine Carrier
Open accessAbstract
In this manuscript, an E1 and E3 deleted adenoviral recombinant expressing the rabies virus glycoprotein (G protein) under the control of the cytomegalovirus early promoter was tested for induction of a rabies virus-specific immune response in mice. The construct was found to induce neutralizing antibodies and cytolytic T cells to rabies virus. Mice vaccinated with the adenoviral construct either by the systemic route or by application into the airways were protected against a subsequent infection with a virulent strain of rabies virus. The efficacy of the replication-defective construct was far superior to that of a well-characterized vaccinia rabies glycoprotein recombinant.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Grubman, M. J., & Baxt, B. (2004) · Clinical Microbiology Reviews · doi:10.1128/cmr.17.2.465-493.2004 · Cited by 1,840
Chitosan-based gastrointestinal delivery systems
Hejazi, R., & Amiji, M. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00126-3 · Cited by 882
Adenoviruses as vaccine vectors
Tatsis, N., & Ertl, H. C. J. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.07.013 · Cited by 669
Self-citationDevelopment of a preventive vaccine for Ebola virus infection in primates
Sullivan, N. J., Sanchez, A., Rollin, P. E., Yang, Z.-Y., & Nabel, G. J. (2000) · Nature · doi:10.1038/35046108 · Cited by 663
DNA-polycation nanospheres as non-viral gene delivery vehicles
Leong, K. W., Mao, H.-Q., Truong-Le, V. L., Roy, K., Walsh, S. M., & August, J. T. (1998) · Journal of Controlled Release · doi:10.1016/s0168-3659(97)00252-6 · Cited by 538
Borchard, G. (2001) · Advanced Drug Delivery Reviews · doi:10.1016/s0169-409x(01)00198-3 · Cited by 534
Pardoll, D. M. (1998) · Nature Medicine · doi:10.1038/nm0598supp-525 · Cited by 428
Current state and challenges in developing oral vaccines
Vela Ramirez, J. E., Sharpe, L. A., & Peppas, N. A. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.04.008 · Cited by 412
Song, W., Kong, H.-L., Carpenter, H., Torii, H., Granstein, R., Rafii, S., Moore, M. A. S., & Crystal, R. G. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.8.1247 · Cited by 379
New Insights on Adenovirus as Vaccine Vectors
Lasaro, M. O., & Ertl, H. C. (2009) · Molecular Therapy · doi:10.1038/mt.2009.130 · Cited by 263
Self-citationYang, Y., Su, Q., & Wilson, J. M. (1996) · Journal of Virology · doi:10.1128/jvi.70.10.7209-7212.1996 · Cited by 262
Self-citationNovel Vaccines to Human Rabies
Ertl, H. C. J. (2009) · PLoS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0000515 · Cited by 93
“In a mouse model for preventative vaccination to rabies, full and long-lasting protection against a severe challenge with rabies virus could be induced with a single moderate dose of an E1-deleted AdHu5 vaccine expressing the rabies virus glycoprotein [78].”
BackgroundInfluentialSelf-citationType I interferon inhibits antibody responses induced by a chimpanzee adenovirus vector.
Hensley, S. E., Cun, A. S., Giles-Davis, W., Li, Y., Xiang, Z., Lasaro, M. O., Williams, B. R. G., Silverman, R. H., & Ertl, H. C. J. (2007) · Molecular Therapy · doi:10.1038/sj.mt.6300024 · Cited by 78
Self-citation
Metadata
- Authors
- XIANG, Z. Q., YANG, Y., WILSON, J. M., & ERTL, H. C. J.
- Venue
- Virology
- Publisher
- Elsevier BV
- Published
- 1996-05
- Volume
- 219
- Issue
- 1
- Pages
- 220-227
- ISSN
- 0042-6822 (ISSN-L)
- OpenAlex
- W1999089101
- Cited by
- 241
- References
- 0
- FWCI
- 2.68
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.